We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Chesnara Plc | CSN | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
270.00 | 266.00 | 271.50 | 268.00 | 266.50 |
Industry Sector |
---|
LIFE INSURANCE |
Top Posts |
---|
Posted at 17/7/2024 17:23 by pvb Interim Results in September? |
Posted at 13/7/2024 08:21 by yump I thought that might be likely, its just that it seems to have reacted a bit later than most income stocks. I suspect I haven’t got to grips with the fact that its income/value is related to interest rates, so that influences investors as well as its yield vs interest rates. |
Posted at 28/3/2024 16:01 by mirandaj Investor Relations shows today's presentation:Scroll down |
Posted at 22/3/2024 11:38 by 1knocker Pleased aabout Phoenix, as I started a holding there last week. Now, of course, I wish I had bought a few more ....We investors are never satisfied! |
Posted at 14/3/2024 08:46 by aleman I haven't seen an RNS notice of the results date this year but the investor calendar says March 28th. |
Posted at 24/2/2024 12:49 by al101uk The company lost a fantastic CEO, the new man decided on a strategy change, followed by an equally fantastic CFO leaving.The new strategy appears to be to take on more debt, pay more for assets and justify the purchases through "business synergies". It's not a surprise that the investor base is rotating, Chesnara should attract the people who invested in Phoenix a few years ago, not the investors who invested here a few years ago. The old guard were happy with a sustainable profitable smaller business. the new wants growth even at the expense of profitabilty imv. That said, I still hold, primarily because of the value at this price, certainly not because of the "hold forever" mentality I once had here. |
Posted at 20/12/2023 12:38 by wmb194 As I've written before, the market doesn't see these companies as sustainable in the long run and hence its management talking about acquisitions and expansion.Plus, according to Investors' Chronicle in September, CSN's NAV is 241p including 76p of intangibles. If you ignore the intangibles that gives a price to book value of 1.58 times (260p / 165p) which to me looks like a full valuation for a company like this. |
Posted at 04/9/2023 20:40 by edmundshaw I agree, I have done similar, but somehow Chesnara's dividend is not so enticing at the moment, with 8 to 10% yields available in a number of solid financial stocks. It is not that I feel Chesnara is weak, but I feel other investors may not be so keen, and also the FT100 is very low given growth and inflation, IMO it should be around 10,000. But a general correction of 35%+ upside might well not lift Chesnara up over £4, so other shares feel like there is more potential upside. I retain a holding here, but I don't feel the urge to add... |
Posted at 31/3/2023 11:54 by speedsgh Six months of chaotic bond markets has slapped a cheaper price tag on insurers. In the wake of the latest upheaval caused by recent banking failures, shares in Chesnara trade at a 19 per cent discount to the group’s economic value, a measure of net assets and future cashflow set to be generated by the business.Yet annual trading figures underline why the closed-book consolidator can withstand a short-term fall in investment returns and crucially, maintain generous dividends. Another 3 per cent rise in the dividend to 23.28p a share extends its record of consecutive dividend increases to 18 years. At the present price, the shares offer a dividend yield of 8.1 per cent. How sustainable is that? Without completing more acquisitions, the existing business is expected to throw off about £300 million in cash over the next five years. That would easily cover the £239 million cost of increasing the dividend by roughly 3 per cent each year plus servicing its debt. Last year alone, cash generated by the group’s British, Dutch and Swedish businesses was £61.9 million, almost twice the £34 million cost of the annual dividend. On one hand, falling equity markets last year meant lower fees earned on policy investments by Chesnara — not good over an extended period. On the other, a sharp decline in stock markets also reduces the level of capital that Chesnara has to hold, as the risk of a further heavy decline diminishes, pushing up cash generation in the short term. That is one reason that, from a regulatory capital position, Chesnara is in solid form. The Solvency II ratio is 182 per cent even after acquisitions, a way above the target range of 140 per cent to 160 per cent. For a closed-book insurance company such as Chesnara, dealmaking is crucial to replace the cash generated by pools of policies as they mature. Three acquisitions have been completed since the start of last year, which should generate annual cash of £10 million. There is about £100 million left for more bolt-on deals, after maintaining between £40 million and £50 million on the balance sheet. It is enough to keep investors secure in dividend prospects. ADVICE Buy WHY A generous dividend at a discounted price |
Posted at 23/2/2022 17:42 by tole https://masterinvest |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions